Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal.

Corrado MinettiRachael BartonCaitlin Farley Owen Brad Spiller Raquel Rodrigues Paulo Gonçalves

Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)

We report, for the first time, elevated MICs against first-line and other antibiotics (including azithromycin, fluoroquinolones and amoxicillin/clavulanic acid commonly used to treat pneumonia patients in Portugal) in Portuguese L. pneumophila strains. Results point towards decreased susceptibility in circulating strains, justifying further investigation.

Keyphrases

escherichia coli
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
patient reported outcomes